14.

15.

16.

17.

18.

patient's dosages without ordering additional urine drug testing to

ensure that they were complying with her prescribed regimen.
in summary, the Respondent prescribed excessive quantities of potent and
highly addictive opioids without medical justification and failed to conduct
appropriate compliance monitoring of the patients to whom she prescribed the
opioids.
UNAUTHORIZED PRACTICE OF MEDICINE
On the morning of April 25, 2017, Board staff transmitted to the Respondent by
email the Order for Summary Suspension of License to Practice Medicine
(“Order”).
Later that morning, Board staff telephoned the Respondent. The Respondent
confirmed that she had read the Order. Board staff informed the Respondent
that she could not see or treat patients until the summary suspension was lifted.
On May 8, 2017, the Board received a complaint from a pharmacist (“Pharmacist
A") that on that date, Pharmacy A had received five prescriptions written by the
Respondent for one patient. The prescriptions were written for oxymorphone ER
30 mg, oxycodone 30 mg, baclofen 10 mg, gabapentin 800 mg and Fioricet with
codeine.
On May 9, 2017, Board staff spoke to Pharmacist A. Pharmacist A informed
Board staff that Pharmacy A had received another prescription from the
Respondent's office on that date. Pharmacist A further advised that Pharmacy A

staff contacted the Respondent to advise her that the pharmacy was not able to
